Technology & Innovation

Electrochemical Interferences in BGM

Electrochemical interference in blood glucose monitoring (BGM) occurs when physical properties of blood or non-glucose substances distort the electrical current measured by the test strip, leading to inaccurate dosing decisions. The most significant physical interference is the Hematocrit Effect, where the volume of red blood cells alters diffusion rates; high hematocrit causes false lows, while low hematocrit causes false highs. Modern meters mitigate this using AC Impedance Spectroscopy to estimate red blood cell volume and algorithmically correct the result.

Chemical interferences arise from redox-active substances (e.g., Acetaminophen, Vitamin C, Uric Acid) that oxidize at the electrode, creating false positive signals. Manufacturers have countered this by developing low-potential mediators (Osmium/Ruthenium) that operate at voltages too low to oxidize these contaminants. Historically, the lack of enzyme specificity in GDH-PQQ strips led to fatal errors in dialysis patients due to Maltose interference, prompting a global industry shift toward GDH-FAD and GDH-NAD chemistries. Additionally, Glucose Oxidase (GOx) sensors must account for dissolved oxygen levels, which can skew results at high altitudes or in venous blood samples.

1 min read
Advanced
6 glossary terms
2 citations

Electrochemical Interferences in Blood [Glucose Monitoring](/)

Introduction

Electrochemical interference distorts blood glucose monitoring (BGM) results. This occurs when physical properties of blood or non-glucose substances alter the electrical current measured by the test strip.

Physical Interferences

The Hematocrit Effect significantly interferes with BGM. High hematocrit levels cause false lows, while low hematocrit levels cause false highs [^hematocrit_effect]. Modern meters use AC Impedance Spectroscopy to estimate red blood cell volume and correct results algorithmically.

Chemical Interferences

Redox-active substances like Acetaminophen, Vitamin C, and Uric Acid create false positive signals [^redox_active_substances]. They oxidize at the electrode, but manufacturers counter this with low-potential mediators. These mediators, such as Osmium/Ruthenium, operate at voltages too low to oxidize contaminants.

Historical Context

GDH-PQQ strips lacked enzyme specificity, leading to fatal errors in dialysis patients due to Maltose interference [^electrochemical_interference]. This prompted an industry shift toward GDH-FAD and GDH-NAD chemistries. Glucose Oxidase (GOx) sensors must account for dissolved oxygen levels, which can skew results at high altitudes or in venous blood samples.

References

  1. FDA Public Health Notification: Potentially Fatal Errors with GDH-PQQ Glucose Monitoring TechnologySource
  2. Self-Monitoring Blood Glucose Test Systems for Over-the-Counter Use: Guidance for IndustrySource

Was this article helpful?

Explore More Topics

Continue your research with related categories